Aptinyx Inc.
Spiro-lactam NMDA receptor modulators and uses thereof

Last updated:

Abstract:

Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.

Status:
Grant
Type:

Utility

Filling date:

1 Aug 2017

Issue date:

30 Mar 2021